MedIntelliBase® NewsTips     March 2007

Your monthly newsletter from the
"better way to access market intelligence" people at

MedIntelliBase® NewsTips...A Better stay up-to-date

Table of Contents
1) 2007 SIR Meeting Late-Breaking Updates - Carotid Therapeutics & Stroke Prevention
2) 2007 SIR Meeting Late-Breaking Updates - Endovascular Interventions
3) New MedIntelliBase Custom Email Alerts 
  • MIB Alerts - Stay up-to-date by email on relevant medical industry publications and announcements as they occur
  • Sign up for your Free Personal Tour of MIB Custom Email Alerts
4) Link of the Month
5) Fun Fact of the Month
6) A Better Access Market Intelligence
7) More Information Available at
Return to Top

1) 2007 Society of Interventional Radiology (SIR) Meeting Late-Breaking Updates - Carotid Therapeutics & Stroke Prevention

CASES PMS update

360-day results from the CASES PMS Trial were presented March 2, 2007 at the 2007 SIR meeting in Seattle, Washington by Dr. Barry T. Katzen, MD, FACR, FSIR, FACC. The study is a multi-center, prospective, single-arm trial of 1,493 patients evaluating the Precise nitinol stent used with the AngioGuard XP embolic protection device, both by Cordis.

The primary endpoints of the study were the 30-day major adverse event rate (MAE), a composite of death, stroke and heart attack and the one-year MAE, which included the 30-day rate plus death and same-side stroke from 31 days to one year.

Preliminary one-year cumulative MAE was 11.9% in the CASES-PMS trial and is similar to the 12.2% rates seen with the SAPPHIRE trial stent arm, and lower than the 20.1% for the surgical arm of the SAPPHIRE trial. The CASES-PMS Trial demonstrated similar results regardless of hospital, physician volume, or
physician experience via a formal training program.

These snapshot SAPPHIRE trial and CASES-PMS trial summaries can be viewed by clicking on their names. They and over 800 other trial summaries are available to subscribers to MedIntelliBase MarketTracks databases. Contact us to access specific clinical trial and registry summaries of interest to you.
Return to Top

Imaging the Heart for Cardioembolic Stroke Prevention

On March 7 at the 2007 SIR meeting Dr. John Sheehan, M.D., of Northwestern University and Northwestern Memorial Hospital in Chicago described a 106-patient retrospective study of individuals with suspected cardioembolic stroke in which a combined echocardiography (ECHO) & magnetic resonance imaging (MRI) approach was demonstrated to detect more potential causes of cardioembolic stroke than using either method alone.

While each imaging technique demonstrated its strengths - ECHO (both transthoracic and transesophageal) was better at detecting shunts and bacterial growths on prosthetic valves, while MRI was better at detecting more clots - Dr. Sheehan noted that combining the two modalities improved detection and treatment of embolic source, which will likely improve secondary prevention of subsequent strokes in this high risk patient group. For more information view our MedIntelliBase Alerts "Interventional Vascular Medicine" archive abstract database.

Return to Top

2) 2007 SIR Meeting Late-Breaking Updates - Endovascular Interventions

Peripheral Artery Disease (PAD) and Critical Leg Ischemia (CLI)

Dr. Nael Saad, M.B., B.Ch., of the University of Rochester (N.Y.) Medical Center described on March 5, 2007 that advances in devices including angioplasty balloons and stents for the treatment of PAD have allowed physicians to treat anatomic locations that were previously difficult or completely inaccessible, particularly those below the knee.

Dr. Saad described a study in which 57 patients had 96 total blockages in 69 limbs at the CLI stage of PAD. 97% were treated successfully, 85% were open at 1 year, 77% were open at 2 years, and 92% avoided amputation through two years of follow-up, with additional revascularization performed when required. For more information view our MedIntelliBase Alerts "Interventional Vascular Medicine" archived abstract database.

Interested in keeping up to date on this issue? Is there another area of interest where you need current, timely clinical research or technology development information? Click here to learn more about our MIB Alerts - A Better stay up to date.

Return to Top

3) MedIntelliBase Alerts
MIB Alerts
Return to Top

4) Link of the Month
  • Invest Northwest 2007- Invest Northwest, the Pacific Northwest's premier CEO and investor forum for the life sciences produced by the Washington Biotechnology & Biomedical Association, will feature the most innovative and topical panel discussions offered in the history of the conference. Invest Northwest, March 20-21, 2007, includes two days of presentations from 57 of the Pacific Northwest’s most innovative life science companies, plus panelists and speakers. If you are interested in attending, please visit the link above. []
Return to Top

5) Fun Fact the Month Return to Top

6) MedIntelliBase Custom Email Alerts now give you A Better Way ...the option of full-featured search capabilities of your:
  • Abstracts Library
  • Alerts Library
  • Full Text Article Library
  • MarketTracks...breaking clinical trial and emerging technologies summaries.
You choose.

Does this "quest for Market Intelligence" sound familiar?
  1. Search for market, clinical, or technology "intelligence"
  2. Agonize over the high prices
  3. “Bite the bullet” and purchase an email alert service
  4. Sort through reams of semi-useful results with every alert
  5. Marvel at the lack of precise targeting and time you spend screening-out bad results
  6. Spend hours trying to find the latest developments on Medline or Google
  7. Search for hours to find that exact abstract or press release from 3 or 4 months ago that supports your point
  8. Get frustrated at the inability to find what you need
  9. Write your report or your business plan that you know should be better, more in depth and precise...if only you had better information
  10. Vow that next time, you’ll find a better way
MedIntelliBase Alerts now with MarketTracks databases give you just that...A Better Way:

      MIB Alerts
MedIntelliBase Custom Email Alerts are highly flexible, customized intelligent search filters powered by "Human Intelligence™" that give you convenient, timely, and tightly focused updates on new developments in your industry segment. MIB Alerts are especially suitable for busy Marketing, Business Development, and General Management executives in medical device and biotechnology companies.
  • Convenient and Timely >>
    • Respond to new developments in real time, not weeks or months later
    • Keep you up-to-date on relevant industry events and announcements as they occur
    • Pushed to you via email, no need to login for news
  • Easy to use >>
    • MIB Alerts do the work for you. You become the "industry expert" in your organization
    • Easy-to-read and navigate alerts and archives
    • Fully-searchable and personal online libraries of abstracts, articles, alerts, clinical trial and technology summaries - you choose
    • Accessible from anywhere, from Outlook or any web browser
  • Customized and Tightly Focused >>
    • Save you time and make you more effective
    • You receive only those specific developments that matter to you
    • You don't receive useless filler and irrelevant search hits - MIB's "Human Intelligence" removes the fluff
A few examples of thousands of possibilities:
Cardiac, Cardiovascular and Vascular
  • Peripheral Arterial Occlusion (PAO)- Thrombolysis
  • Cardiac Structural Defects
  • Lower Limb PAD & Atherectomy
  • PV Angiography - Infusion Catheters
  • CV/PV Angiography - Power Injectors
  • Deep Vein Thrombosis (DVT) - Thrombolysis
  • Vascular Access Closure Devices - coming soon
  • Neurostimulation - Hearing Loss
  • Neurostimulation - Alzheimer's disease
  • Neurostimulation - Parkinson's disease
  • Drugs and Advanced Therapies - Parkinson's disease & Essential Tremor
  • Neurostimulation - Epilepsy
  • Spinal Motion Preservation
  • Hip Resurfacing - coming soon
  • Knee Resurfacing - coming soon
Emergency Medicine
  • Resuscitation
View a sampling of Custom Email Alerts
The type of information you specify:
  • Clinical article abstracts
  • Trials and registries results
  • Preclinical article abstracts
  • Industry announcements
  • Press releases
  • Conference notices & proceedings
  • Technology developments
  • Patents issued & challenged
  • Lawsuits & other legal issues
  • FDA & voluntary product recalls
  • And more
Other custom consulting options:
  • Tracking of established and emerging technologies, landmark and breaking trials and competing companies
  • Strategic analysis and recommendations
  • Market potential assessments
Click the banner below to view sample MIB Custom Email Alert formats - a Full Alert, or one of the "QuickView" formats --> Lean Alert or UltraLean Alert:

MIB Alerts

You get much greater value from customizable MIB Alerts than from standard market reports and search engines. You choose the exact depth and breadth of intelligence required, realizing the greatest value for your market intelligence money.

Interested? Want to know more? Want a trial?

Contact us for:
  • More information
  • Real-Time MedIntelliBase Custom Email Alerts  Tour
Return to Top

7) More Information Available at

You can find more in-depth information about MedIntelliBase Custom Email Alerts - visit the website at or request more information on the site.

MedIntelliBase MarketTracks and Alerts will help you find the critical intelligence you need to make informed product development and business investment decisions.

Contact MedIntelliBase directly...

Return to Top

  1. MedIntelliBase NewsTips is free and you are welcome to continue receiving it as long as you wish. If at any time you wish to cancel just click the Safe Unsubscribe link below.
  2. We will not share your name and e-mail address with anyone.
  3. Feel free to share or reproduce the information in this MedIntelliBase NewsTips e-newsletter (in whole or part) as long as proper mention and copyright notice is given to MedIntelliBase and The Next Phase Publishing**.
  4. If you are not the original recipient of this newsletter and would like to receive future issues, just click the Forward link below or drop us a line.

Editor: Vicky Hunsicker Sanko
The Next Phase Publishing**

Market Research Analyst: Jordan Zornes
The Next Phase Publishing**
Phone - 425/894-4147
Toll Free - 800/390-2756
Fax - 866/381-6119

** A division of Next Phase® Consultancy, Inc.

© The Next Phase® Consultancy, Inc. 2007. All rights reserved.

Return to Top